Apollomics Inc (NASDAQ: APLM) has experienced a rise in its stock price by 6.13 compared to its previous closing price of 5.55. However, the company has seen a gain of 3.66% in its stock price over the last five trading days. globenewswire.com reported 2025-04-03 that FOSTER CITY, Calif., April 03, 2025 (GLOBE NEWSWIRE) — Apollomics Inc. (Nasdaq: APLM) (“Apollomics”), a late-stage clinical biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and treatment-resistant cancers, today announced financial results for the fiscal year ended December 31, 2024, and highlighted clinical updates and business progress.
Is It Worth Investing in Apollomics Inc (NASDAQ: APLM) Right Now?
APLM has 36-month beta value of 0.94. Analysts have mixed views on the stock, with 1 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for APLM is 0.74M, and currently, short sellers hold a 0.39% ratio of that float. The average trading volume of APLM on April 17, 2025 was 21.96K shares.
APLM’s Market Performance
The stock of Apollomics Inc (APLM) has seen a 3.66% increase in the past week, with a -26.01% drop in the past month, and a -40.62% fall in the past quarter. The volatility ratio for the week is 20.32%, and the volatility levels for the past 30 days are at 19.70% for APLM. The simple moving average for the past 20 days is -17.05% for APLM’s stock, with a -49.69% simple moving average for the past 200 days.
APLM Trading at -18.17% from the 50-Day Moving Average
After a stumble in the market that brought APLM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -89.84% of loss for the given period.
Volatility was left at 19.70%, however, over the last 30 days, the volatility rate increased by 20.32%, as shares sank -26.01% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -34.48% lower at present.
During the last 5 trading sessions, APLM rose by +3.70%, which changed the moving average for the period of 200-days by -72.07% in comparison to the 20-day moving average, which settled at $7.10. In addition, Apollomics Inc saw -39.59% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for APLM
Current profitability levels for the company are sitting at:
- -18.6 for the present operating margin
- 1.0 for the gross margin
The net margin for Apollomics Inc stands at -21.97. The total capital return value is set at -6.86. Equity return is now at value -233.67, with -157.28 for asset returns.
Based on Apollomics Inc (APLM), the company’s capital structure generated 0.17 points at debt to capital in total, while cash flow to debt ratio is standing at -26.29.
Currently, EBITDA for the company is -171.75 million with net debt to EBITDA at 0.23. When we switch over and look at the enterprise to sales, we see a ratio of -1.1. The receivables turnover for the company is 16.55for trailing twelve months and the total asset turnover is 0.16. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.39.
Conclusion
To put it simply, Apollomics Inc (APLM) has had a bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
